NCT07177274

Brief Summary

Chronic wounds and impaired healing remain a major clinical challenge, particularly in patients with diabetes, vascular disease, or age-related skin fragility. Low-level laser therapy (LLLT) at 660 nm has been reported to enhance tissue repair, reduce inflammation, and promote angiogenesis. However, the biomechanical properties of wound tissue following LLLT remain poorly understood. Optical Coherence Tomography (OCT) provides a non-invasive, high-resolution method to assess skin microstructure and elasticity, while the MyotonPRO offers quantitative stiffness measurements at the tissue surface. Combining these two complementary modalities may provide a more comprehensive assessment of wound healing progression and treatment response. This study aims to evaluate changes in wound stiffness before and after 660 nm LLLT and to compare them against contralateral normal skin, thereby providing objective insight into the biomechanical efficacy of laser treatment.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 19, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 10, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 16, 2025

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2025

Completed
Last Updated

September 16, 2025

Status Verified

September 1, 2025

Enrollment Period

10 months

First QC Date

September 10, 2025

Last Update Submit

September 10, 2025

Conditions

Keywords

StiffnessWoundSkinLow-Level Laser Therapy

Outcome Measures

Primary Outcomes (1)

  • To evaluate changes in skin stiffness of wound tissue before and after LLLT using OCT and MyotonPRO.

    1 year

Secondary Outcomes (1)

  • To compare wound skin stiffness with contralateral normal skin.

    1 year

Study Arms (2)

Skin status (normal, wound, after treatment)

ACTIVE COMPARATOR

Using 660 nm LLLT efficacy on the wound, separated categories into the upper limb and lower limb.

Radiation: Low Level Laser Therapy

Skin location (upper limb, lower limb)

ACTIVE COMPARATOR

Using 660 nm LLLT efficacy on the wound, separated categories into the upper limb and lower limb.

Radiation: Low Level Laser Therapy

Interventions

Collecting wound stiffness data using the OCT-air-jet and Myoton Pro before and after the LLLT treatment using the device's indentation system. Then the intervention is applying LLLT to the wound for 3 min. The LLLT utilized the Red Dot Laser Diode Module Class IIIA.

Also known as: 660 nm LLLT
Skin location (upper limb, lower limb)Skin status (normal, wound, after treatment)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • presented chronic and burn wounds lasting more than four weeks.
  • had partial-thickness burn wounds.

You may not qualify if:

  • current smokers.
  • wounds that were fresh and still bleeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asia University

Taichung, Wufeng, 41354, Taiwan

Location

MeSH Terms

Conditions

Wounds and Injuries

Interventions

Low-Level Light Therapy

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2025

First Posted

September 16, 2025

Study Start

September 19, 2024

Primary Completion

July 24, 2025

Study Completion

September 20, 2025

Last Updated

September 16, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations